Posted inMarket H.C. Wainwright Reaffirms Buy Rating for Milestone Pharmaceuticals Following Regulatory Nod in China H.C. Wainwright maintains its Buy rating for Milestone Pharmaceuticals following a significant regulatory approval in China. Posted by Prasenjit Bhowmik October 3, 2026
